LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects

Diabetes Care

Volumn 21, Issue 12, 1998, Pages 2077-2084

  Ambrosch, Andreas ^a   Mühlen, Isabel ^a   Kopf, Daniel ^a   Augustin, Wolfgang ^a   Dierkes, Jutta ^a   König, Wolfgang ^a   Luley, Claus ^a   Lehnert, Hendrik ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORRELATION FUNCTION; DISEASE PREDISPOSITION; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MALE; PHENOTYPE; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0031737794     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.12.2077     Document Type: Article

References (54)

1. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willeft WS, Krauss RM: Low density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 260:1917-1924, 1988
2. Austin MA, King MC, Vranizian KM, Krauss RM: Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease. Circulation 82:495-506, 1990
3. Austin MA, Krauss RM: Genetic control of low density lipoprotein subclasses. Lancet ii:592-595, 1986
4. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM: Inheritance of low density lipoprotein subclass pattern: results from complex segregation analysis. Am J Hum Genet 43:838-846, 1988
5. LaBelle M, Austin MA, Rubin E, Krauss RM: Linkage analysis of low-density subclass phenotypes and the apolipoprotein B gene. Genet Epidemiol 8:269-275, 1991
6. Nishina PM, Johnson JP, Naggert KJ, Krauss RM: Linkage in atherogenic lipoprotein phenotype to the low-density lipoprotein receptor locus on the short chromosome 19. Proc Natl Acad Sci U S A 89:708-711, 1992
7. Reaven GM, Chen YDI, Jeppesen J, Mabeaux P, Krauss RM: Insulin resistance and hyperinsulinemia in individuals with small dense low density lipoprotein particles. J Clin Invest 92:141-146, 1993
8. Barakat HA, Carpenter JW, McLendon VD: Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 39:1527-1533, 1990
9. Haffner SM, Mykkänen L, Robbins D, Valdez R, Miettinen H, Howard By Stern MP, Bowsher R: A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 38:1328-1336, 1995
10. Grundy SMA, Chait A, Brunzell JD: Familial combined hyperlipidemia workshop. Arteriosclerosis 7:203-207, 1989
11. Homma Y, Nakaya N, Nakamura H, Goto Y: Increase in the density of lighter low density lipoproteins by hepatic triglyceride lipase. Artery 13:19-31, 1985
12. Eisenberg S, Gavish D, Oschtry Y, Fainaru M, Deckelbaum RG: Abnormalities in very low, low and high density lipoproteins and hypertriglyceridemia: reverse toward normal with bezafibrate treatment. J Clin Invest 74:470-482, 1984
13. Ohta T, Kakiuti Y, Kurahara K, Saku K, Nagata N, Matsuda I: Fractional esterification rate of cholesterol in high density lipoprotein is correlated with low density lipoprotein particle size in children. J Lipid Res 38:139-146, 1997
14. Lagrost L, Gandjini H, Athias A, Guyard- Dangrement V, Lallement C, Gambert P: Influence of plasma cholesterol ester transfer activity on the LDL and HDL distribution in normolipidemic subjects. Arteriosder Thromb 13:815-825, 1993
15. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
16. Rainwater DL, Andres DW, Ford AL, Lowe F, Blanche PJ, Krauss RM: Production of polyacrylamide gradient gels for electrophoretic resolution of lipoproteins. J Lipid Res 33:1876-1881, 1992
17. Williams PT, Krauss RM, Nichols AV, Vranzian KM, Woods PDS: Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. J Lipid Res 31:1131-1139, 1990
18. Ambrosch A, Tato F, Luley C: Fluorescent determination of CETP activity in plasma. Atherosclerosis 134(Suppl.):100, 1997
19. Haffner SM, Mykkanen L, Stern MP, Paidi M, Howard BV: Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17:1164-1171, 1994
20. Feingold KTR, Grunfeld C, Pang M, Doerrler W, Krauss RM: LDL subclass phenotypes and triglyceride metabolism in non-insulin dependent diabetes. Arterioscler Thromb 12:1496-1502, 1992
21. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R: Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 39:1527-1533, 1990
22. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM: Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92:141-146, 1993
23. Mykännen L, Haffner SM, Rönnemaa T, Bergman R, Leino A, Laakso M: Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins? Metabolism 43:523-528, 1994
24. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Depres JP: Sex differences in relation of visceral adipose tissue to total body fatness. Am J Clin Nutr 58:463-467, 1993
25. Lemieux S, Depres JP, Moorjani S, Nadeau A, Theriault G, Prud'homme D, Tremblay A, Bouchard C, Lupien JP: Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue. Diabetologiu 37:757-764, 1994
26. Radhakrishnamurthy B, Srinivasan SR, Webber LS, Dalferes ER, Berenson GS: Relationship of carbohydrate intolerance to serum lipoprotein profiles in childhood: the Bogalusa Mean Study. Metabolism 34:850-860, 1985
27. Srinivasan SR, Sundaram GS, Williamson GD, Webber LS, Berenson GS: Serum lipoproteins and endogenous sex hormones in early life: observations in children with differences in lipoprotein profiles. Metabolism 34:861-870, 1985
28. Kissebah AH, Peins AN: Biology of regional body fat distribution: relationship to non- insulin-dependent diabetes mellitus. Diabetes Metab Rev 5:83-109, 1989
29. Dupres JP: Dyslipidemia and obesity Baillieres Clin Endocrinol Metab 8:629-660, 1994
30. Greenlund KJ, Webber LS, Shrinivasan S, Wattigney W, Johnson C, Berenson G: Association of oral contraceptive drugs with serum lipids and lipoproteins on young women: the Bogalusa Study. Ann Epidemiol 7:561-567, 1997
31. Benagniago G, Primiero FM, Bastianelli C, Bianchi P, Medda E: Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and Trinovum, Contraception 55:287-294, 1997
32. Manning JM, Edwards IJ, Wagner DM, Wagner JD, Adams MR. Parks JS: Effects of contraceptive estrogens and progestin on the atherogenic potential of plasma LDLs in cynomoglus monkeys. Arterioscler Thromb Vasc Biol 176:1216-1223, 1997
33. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J: Role of plasma triglycerides in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106:241-253, 1994
34. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D: Disproportionate elevation of immunoreactive proinsulin in type-2 (NIDDM) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-704, 1987
35. Tan KCB, Cooper MB, Ling KLE, Griffin BA, Freeman DJ, Pacherd CJ, Shepherd J, Hales CM, Batteridge DJ: Fasting and postprandial determinants for the occurrence of small dense LDL species in NIDDM patients with and without hypertriglyceridemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 113:275-284, 1995
36. Lahdenperä S, Sane T, Vuorinen-Markkola H, Knudsen P, Taskinen MR: LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes. Atherosclerosis 113:2217-2236, 1995
37. Stewart MW, Laker MF, Dyer RG, Game F, Mitchenson J, Wincour PH, Alberti KGMM: Lipoprotein compositional abnormalities in type II diabetic patients with mild hypertrigylecridemia. Arterioscler Thromb 13:1046-1051, 1993
38. Tall A: Plasma lipid transfer proteins . J Lipid Res 27:361-367, 1988
39. Deckelbaum RJ, Eisenberg S, Oschry Y, Butbul E, Sharon I, Olivecrano T: Reversible modification of human plasma low density lipoproteins towards triglyceride-rich precursors: a mechanism for losing excess cholesterol esters, J Biol Chem 257:6509-6517, 1982
40. Tall AR, Sammet D, Vita G, Deckelbaum RJ, Olivecrano T: Lipoprotein lipase enhanced the cholesteryl ester transfer protein-mediated transfer of cholesteryl-esters from high- density lipoproteins to very-low density lipoproteins. J Biol Chem 259:9587-9594, 1984
41. Deckelbaum RJ, Eisenberg S, Fainaru M, Barenholz Y, Olivecrano T: In-vitro production of human low density lipoproteinlike particle: a model for very low density lipoprotein catabolism, J Biol Chem 254:6079-6087, 1979
42. Patsch JR, Prasad S, Gotto AM, Patsch W: High density lipoprotein 2: relationship of the plasma levels of lipoprotein species to its composition, to the magnitude of postprandial lipemia and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 80:341-347, 1987
43. Hannuksela M, Marcel YL, Kesäniemi YA. Savolainen MJ: Reduction of the concen tration and activity of cholesterol ester transfer protein by alcohol. J Lipid Res 33:737-744, 1992
44. Demant T, Carlson LA, Holmquist L, Karpe F, Nilsson-Ehle P, Packard CJ, Shepherd J: Lipoprotein metabolism in hepatic lipase deficiency: studies on turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoproteins. J Lipid Res 29:1603-1611, 1988
45. Lagrost L, Gambert P, Lallement C: Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb 14:1327-1336, 1994
46. McPherson R, Mann CJ, Tall A, Hogue M, Martin L, Milne RW, Marcel YL: Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia: relation with cholesteryl ester transfer activity and other lipoprotein variables. Arterioscler Thromb 11:797-804, 1991
47. Ritter MC, Bagdade JD: Contribution of glycemic control, endogenous lipoproteins and cholesterol ester transfer protein to accelerated cholesteryl ester transfer in IDDM. Eur J Clin Invest 24:607-614, 1994
48. Freeman D, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, Shepherd J: Regulation of plasma cholesterol levels and subfraction distribution by genetic and environmental factors: an association between TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 14:336-344, 1994
49. Groener JEM, VanRamshorst EM, Katan MB, Mensink RP, Van Tol A: Diet-induced alteration in the activity of plasma lipid transfer protein in normolipidemic human subjects. Atherosclerosis 87:221-226, 1991
50. Dullaart RPF, Hoogenberg K, Dikkeschei BD, Van Tol A: Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Aterioscler Thromb 14:1581-1585, 1994
51. Mann CJ, Yen FT, Grant AM, Bihain BE: Mechanism of cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 88:2059- 2066, 1991
52. Murakami T, Michelagnoli S, Linghi R, Gianfranceschi G, Pazzucconi F, Calabresi L, Sirtori CR, Franceschini G: Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 15:1819-1828, 1995
53. Bagdade JD, Ritter MC, Subbaiah PV: Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 21:161-167, 1991
54. Hirano T, Naito H, Kurokawa M, Ebara T, Nagano S, Adachi M, Yoshino G: High prevalence of small dense LDL particles in NIDDM patients with nephropathy. Atherosclerosis 123:57-72, 1996